Related Experiment Video
Updated: Aug 19, 2026

Transmembrane Domain Oligomerization Propensity determined by ToxR Assay
Published on: May 26, 2011
Structure, orientation, and conformational changes in transmembrane domains of multidrug transporters
Catherine Vigano1, Liliana Manciu, Jean-Marie Ruysschaert
1Laboratory for Structure and Function of Biological Membranes, Structural Biology and Bioinformatics Center, Free University of Brussels, Brussels, Belgium.
Abstract:
Multidrug transporter proteins promote the active transmembrane efflux of noxious drugs, thereby decreasing their accumulation in the intracellular medium and reducing their therapeutic efficiency. Expression of such proteins drastically reduces the efficiency of chemotherapeutic treatments against cancer and various infectious diseases. To overcome major difficulties related to the crystallization of membrane proteins, other experimental approaches have been developed to gain information on the structural changes involved in drug transport. We examine here and illustrate with a few examples how infrared and fluorescence spectroscopy can provide new insights into the structure of the membrane domains of multidrug transporters in particular. Such domains contain the drug-binding site(s) and mediate the passage of substrates across the cell membrane.
Insights
Multidrug transporter proteins reduce drug efficacy. Infrared and fluorescence spectroscopy offer new insights into the structure of these membrane proteins, aiding in overcoming challenges in drug transport research.
Area of Science:
- Biochemistry
- Molecular Biology
- Structural Biology
Background:
- Multidrug transporter proteins actively efflux drugs, lowering therapeutic efficiency.
- These proteins are a major hurdle in cancer and infectious disease chemotherapy.
- Crystallization of membrane proteins is challenging, necessitating alternative structural analysis methods.
Purpose of the Study:
- To explore the utility of spectroscopy in understanding multidrug transporter structure.
- To provide insights into the membrane domains of multidrug transporters.
Main Methods:
- Examination of infrared spectroscopy for structural analysis.
- Illustration using fluorescence spectroscopy for insights into membrane protein domains.
Main Results:
- Spectroscopic methods provide valuable data on multidrug transporter structure.
- Insights into the drug-binding sites within membrane domains were gained.
Conclusions:
- Infrared and fluorescence spectroscopy are powerful tools for studying multidrug transporters.
- These techniques offer a viable alternative to crystallization for understanding drug transport mechanisms.
Related Concept Videos
Insertion of Multi-pass Transmembrane Proteins in the RER
The multipass transmembrane proteins are the type IV integral membrane proteins with multiple topogenic sequences determining their spatial arrangement in the ER membrane. Nearly all multipass proteins lack a cleavable signal sequence and use...
Multi-pass Transmembrane Proteins and β-barrels
α-Helix containing multi-pass transmembrane proteins
Multi-pass transmembrane proteins such as G-protein-linked receptors (GPCRs) and...
Single-pass Transmembrane Proteins
Membrane Asymmetry Regulating Transporters
Flippase
Eukaryotic flippases are type-IV P-type ATPases or P4-ATPases belonging to P-type ATPase family proteins that are membrane-bound pumps involved in the ATP-mediated transport of ions and molecules across the membrane. Flippases flip specific phospholipids from the outer to the inner leaflet of a membrane. All P4-ATPases have one...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...
The Significance of Membrane Transport
Transporters facilitate either an active or passive movement of solutes. They can allow a single-molecule transport down its...

